Attached files
| file | filename |
|---|---|
| 10-Q/A - NUTRA PHARMA CORP | v207226_10q-a.htm |
| EX-31.1 - NUTRA PHARMA CORP | v207226_31-1.htm |
CERTIFICATION
PURSUANT TO
18
U.S.C. SECTION 1350,
AS
ADOPTED PURSUANT TO
SECTION
906 OF THE SARBANES-OXLEY ACT OF 2002
In
connection with the Quarterly Report of Nutra Pharma Corp., (the "Company") on
Form 10-Q/A for the quarterly period ended September 30, 2010, as filed
with the Securities and Exchange Commission on the date hereof (the "Report"),
I, Rik Deitsch, the Chief Executive Officer and Chief Financial Officer of the
Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to
Section 906 of the Sarbanes-Oxley Act of 2002, that:
|
1.
|
The
Report fully complies with the requirements of Section 13(a) or 15(d) of
the Securities Exchange Act of 1934;
and
|
|
2.
|
The
information contained in the Report fairly presents, in all material
respects, the financial condition and results of operations of the
Company.
|
|
Dated:
January 5, 2011
|
||||
|
/s/
Rik J. Deitsch
|
|
|||
|
Rik
J. Deitsch
|
|
|||
|
Chief
Executive Officer and Chief Financial
Officer
|
|